HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Despite potential, data on vitamin D’s benefits for cancer remain inconclusive
-
- Should clinicians recommend vitamin D supplementation to patients with cancer to improve their outcomes?
- ‘Insuring’ better outcomes John Sweetenham, MD, FRCP, FACP
- Provider messaging, lack of school requirements limit discussion of HPV vaccine
- Recent advances push forward the field of molecular oncology Wafik S. El-Deiry, MD, PhD, FACP
- Risk-adapted approach may help some children with medulloblastoma avoid radiation, chemotherapy
- CAR T-cell therapy ‘quite promising’ for glioblastoma
- Daily aspirin may reduce ovarian cancer risk, extend survival
- ‘Futile’ neutropenic diets should be abandoned for individuals with cancer
-
- Studies of immunotherapy for prostate cancer yield encouraging results
- Guidelines intended to accelerate diagnosis, improve management of von Willebrand disease
- Generic drugs may not reduce costs of cancer care as much as expected
- ASCO issues ‘more structured guideline’ for metastatic pancreatic cancer
- Guest Commentary: Targeted therapies appear effective in breast cancer subtypes
- Accurate sarcoma disease coding crucial to maintain valid databases
- One-third of oncologist authors fail to disclose industry payments
- Accelerated radiotherapy for breast cancer does not harm quality of life
-
- Genetic testing low among medically underserved women with breast, ovarian cancers
- Six gene mutations linked to pancreatic cancer
- Regorafenib after sorafenib lengthens OS for advanced liver cancer
- Modified chemotherapy regimen shows promise for advanced anal squamous cell carcinoma
- Liver disease linked to lower risk for venous thromboembolism
- Insurance status may impact follicular lymphoma survival
- Access to prescription drug coverage improves myeloma survival
- Ibrutinib active, safe in Waldenström’s macroglobulinemia
-
- Advanced practice providers play increasing role in oncology care team
- Filgrastim biosimilars show ‘substantial uptake’ among Medicare beneficiaries
- Use of complementary medicine linked to greater risk for cancer death
- Incidence of lung cancer greater among young women
- Lung cancer screening skewed toward white individuals may increase racial disparities
- Socioeconomic status may explain racial, ethnic disparities in childhood cancers
- Adolescents treated at pediatric cancer centers incur higher costs
- Patients with head, neck cancers at excess risk for second primary malignant neoplasms
-
- Regular sunscreen use lowers melanoma risk among young adults
- Vadastuximab talirine induces modest benefit for acute myeloid leukemia
- American Cancer Society creates blueprint to reduce cancer mortality by 2035
- More than 18 million new cancer cases expected worldwide this year
- FDA grants priority review to Keytruda for PD-L1-positive NSCLC
- FDA grants fast track designation to CX-01 for acute myeloid leukemia
- FDA grants RET inhibitor breakthrough therapy designation for lung, thyroid cancers
- FDA approves Lumoxiti for pretreated hairy cell leukemia
-
- FDA approves Jivi for prophylactic treatment of hemophilia A
- Association of Community Cancer Centers to present Innovator Awards
- Prostate Cancer Foundation presents Young Investigator Awards
- Fox Chase Cancer Center appoints general surgery division chief